These results demonstrate a superiority of human CAR lymphocytes over human CAR macrophages in glioblastoma cell killing and support an anti-tumor benefit if CAR lymphocytes are transfected to co-express IL-12 and IFNα2. Here, IFNA2 is linked to neoplasm.